Trial Profile
Observational study of first-line therapy including cetuximab in patients with metastatic colorectal cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Apr 2020
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Antineoplastics
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms CORAL
- 20 Aug 2019 Status changed from active, no longer recruiting to completed.
- 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology.
- 17 Aug 2015 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.